Skip to main content
. 2019 Mar 25;2019:7403978. doi: 10.1155/2019/7403978

Figure 1.

Figure 1

TDQ mitigated the insulin resistance of type 2 diabetic rats. (a) Body weight over time in each groups. (b–d) Fasting blood glucose (FBG) and oral glucose tolerance tests (OGTT) and area under the curve (OGTT-AUC) were calculated in rats at the end of the 5-week experimental protocol. (e, f) Circulating insulin (FINS), calculated HOMA-IR, and HOMA-IS in each group. Results are shown as the mean ± SD. ∗P < 0.05 and ∗∗P < 0.01 vs. Con; #P < 0.05 and ##P < 0.01 vs Mod. Con: control group, Mod: model group, TDQ: Tangduqing granules, PIO: pioglitazone group.